Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death
byDana-Farber Cancer InstituteCredit: Anna Tarazevich from PexelsHigh-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-recep
Updated on: August 05,2026
Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death
byDana-Farber Cancer InstituteCredit: Anna Tarazevich from PexelsHigh-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-recep
Updated on:August 05,2026
